Transcranial Direct-Current Stimulation (tCDS) and Robotics for Children With Hemiplegia
1 other identifier
interventional
40
1 country
1
Brief Summary
Hemiplegia occurs when the function of motor areas in the brain become impaired, predominantly unilaterally, during perinatal development. Children with hemiplegia show impairments in motor control of the affected side of the body. Impairments in use of the upper extremity are common, and lead to functional disability throughout the lifespan of a person with hemiplegia. Upper extremity impairments can severely affect a person's ability to carry out activities of daily living. The goal of this study at Blythedale Children's Hospital is to test the efficacy of transcranial direct current stimulation (tDCS) and robotic upper extremity therapy in improving upper extremity function in children with unilateral cerebral palsy. This study will test the hypothesis that physical rehabilitation, provided by repetitive arm movements guided by a robot, will improve upper extremity function in children with hemiplegia, and that this improvement can be enhanced by transcranial direct current stimulation of motor cortex immediately before robotic training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2017
CompletedFirst Posted
Study publicly available on registry
May 9, 2017
CompletedStudy Start
First participant enrolled
June 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedJanuary 10, 2022
January 1, 2022
6 years
May 4, 2017
January 5, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Change in Assisting Hand Assessment after intervention
Assessment of how well children incorporate both hands into bimanual task performance, using an assessment tool called the "Assisting Hand Assessment"
Within one week after the intervention ends
Change in Jebsen-Taylor Test of Hand Function after intervention
Assessment of unimanual movement speed
Within one week after the intervention ends
Change in Box and blocks test after intervention
Assessment of unimanual function
Within one week after the intervention ends
Study Arms (2)
Real tDCS plus robotic training
EXPERIMENTALChildren will receive 20 min of real tDCS stimulation per session, followed by robotic training for 1 hr.
Sham tDCS plus robotic training
SHAM COMPARATORChildren will receive 20 min of sham tDCS stimulation per session, followed by robotic training for 1 hr.
Interventions
Children will first receive 20 min of tDCS (real or sham, see Arms), then will receive 1 hr of upper limb robotic therapy in which the child will use their impaired arm and hand to move a joystick controlling a cursor to a set of targets on a video screen in front of the child.
Eligibility Criteria
You may qualify if:
- Age 6-17
- Participant and caregiver willing and able to provide informed consen/assent
- Diagnosis of hemiplegia
- Joint mobility: wrist extension, 20º, metacarpophalangeal and proximal interphalangeal joints 10º
You may not qualify if:
- Cognitive deficits that impede understanding of study protocol
- Current medical illness unrelated to CP
- Visual problems (uncorrected by glasses/contact lenses)
- High motor ability in affected arm Pre-intervention screening measures; Motor activity log, score \> 2.5 ( \> slight-to-moderate)
- Severe spasticity Pre-intervention screening measures; Modified Ashworth test, score \> 3 ( \> moderate)
- Lack of asymmetry in hand function
- Orthopedic surgery in affected arm within 2 years
- Dorsal root rhizotomy
- Botulinum toxin therapy in either upper extremity during last 2 months, or planned during study period
- Currently receiving intrathecal baclofen
- Seizure beyond age 2, use of anti-seizure medication, history of epilepsy (in self or first degree relatives), brain surgery, cranial metal implants, structural brain lesion, devices that may be affected by TMS (pacemaker, medication pump, cochlear implant, implanted brain stimulator)
- True positive response on the Transcranial Magnetic Stimulation Safety Screen
- Current use of medications known to lower the seizure threshold
- Previous episode of neurocardiogenic syncopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kathleen Friel
Valhalla, New York, 10605, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- tDCS will be blinded in that even children in the sham group will receive a low level of stimulation for a brief period.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Cerebral Palsy Research
Study Record Dates
First Submitted
May 4, 2017
First Posted
May 9, 2017
Study Start
June 12, 2017
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
January 10, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
The investigators plan to share deidentified data in the NIH DASH (Data and Specimen Hub) database, sponsored by the National Institute of Child Health and Development (NICHD). Data will be archived to DASH upon study completion.